↓ Skip to main content

Silencing of Jagged1 inhibits cell growth and invasion in colorectal cancer

Overview of attention for article published in Cell Death & Disease, April 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
70 Dimensions

Readers on

mendeley
63 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Silencing of Jagged1 inhibits cell growth and invasion in colorectal cancer
Published in
Cell Death & Disease, April 2014
DOI 10.1038/cddis.2014.137
Pubmed ID
Authors

Y Dai, G Wilson, B Huang, M Peng, G Teng, D Zhang, R Zhang, M P A Ebert, J Chen, B C Y Wong, K W Chan, J George, L Qiao

Abstract

Dysregulated Notch signaling has a critical role in the tumorigenesis. Jagged1, a Notch ligand, is overexpressed in various human cancers. Recent studies revealed the involvement of Jagged1 in colorectal cancer (CRC) development. These basic studies provide a promising potential for inhibition of the Notch pathway for the treatment of CRC. Herein, we aimed to investigate the consequences of targeting Jagged1 using shRNA on CRC both in vitro and in vivo to test their potential to inhibit this key element for CRC treatment. We found that downregulation of Jagged1 with lentiviral Jagged1-shRNA resulted in decreased colon cancer cell viability in vitro, most likely mediated through reduced cell proliferation. Importantly, Jagged1 knockdown induced G0/G1 phase cell cycle arrest, with reduced Cyclin D1, Cyclin E and c-Myc expression. Silencing of Jagged1 reduced the migration and invasive capacity of the colon cancer cells in vitro. Furthermore, colon cancer cells with knockdown of Jagged1 had much slower growth rate than control cells in a xenograft mouse model in vivo, with a marked downregulation of cell proliferation markers (PCNA, Ki-67, and c-Myc) and metastasis markers (MMP-2 and MMP-9). These findings rationalize a mechanistic approach to CRC treatment based on Jagged1-targeted therapeutic development.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 63 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 63 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 21 33%
Researcher 12 19%
Student > Master 11 17%
Student > Bachelor 5 8%
Student > Doctoral Student 3 5%
Other 5 8%
Unknown 6 10%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 19 30%
Medicine and Dentistry 13 21%
Agricultural and Biological Sciences 12 19%
Pharmacology, Toxicology and Pharmaceutical Science 4 6%
Environmental Science 1 2%
Other 4 6%
Unknown 10 16%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 April 2014.
All research outputs
#14,195,272
of 22,754,104 outputs
Outputs from Cell Death & Disease
#3,038
of 6,420 outputs
Outputs of similar age
#121,059
of 228,162 outputs
Outputs of similar age from Cell Death & Disease
#40
of 84 outputs
Altmetric has tracked 22,754,104 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,420 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one is in the 48th percentile – i.e., 48% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 228,162 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 84 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.